Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 1
2002 1
2006 2
2007 1
2009 1
2020 1
2021 4
2022 7
2023 5
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.
Staessen JA, Wendt R, Yu YL, Kalbitz S, Thijs L, Siwy J, Raad J, Metzger J, Neuhaus B, Papkalla A, von der Leyen H, Mebazaa A, Dudoignon E, Spasovski G, Milenkova M, Canevska-Taneska A, Salgueira Lazo M, Psichogiou M, Rajzer MW, Fuławka Ł, Dzitkowska-Zabielska M, Weiss G, Feldt T, Stegemann M, Normark J, Zoufaly A, Schmiedel S, Seilmaier M, Rumpf B, Banasik M, Krajewska M, Catanese L, Rupprecht HD, Czerwieńska B, Peters B, Nilsson Å, Rothfuss K, Lübbert C, Mischak H, Beige J; CRIT-CoV-U investigators. Staessen JA, et al. Among authors: rothfuss k. Lancet Digit Health. 2022 Oct;4(10):e727-e737. doi: 10.1016/S2589-7500(22)00150-9. Epub 2022 Aug 31. Lancet Digit Health. 2022. PMID: 36057526 Free PMC article.
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.
Wendt R, Thijs L, Kalbitz S, Mischak H, Siwy J, Raad J, Metzger J, Neuhaus B, Leyen HV, Dudoignon E, Mebazaa A, Spasovski G, Milenkova M, Canevska-Talevska A, Czerwieńska B, Wiecek A, Peters B, Nilsson Å, Schwab M, Rothfuss K, Lübbert C, Staessen JA, Beige J; CRIT-COV-U investigators. Wendt R, et al. Among authors: rothfuss k. EClinicalMedicine. 2021 Jun;36:100883. doi: 10.1016/j.eclinm.2021.100883. Epub 2021 May 3. EClinicalMedicine. 2021. PMID: 33969282 Free PMC article.
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort.
Freise NF, Gliga S, Fischer J, Lübke N, Lutterbeck M, Schöler M, Bölke E, Orth HM, Feldt T, Roemmele C, Wilke D, Schneider J, Wille K, Hohmann C, Strauss R, Hower M, Ruf A, Schubert J, Isberner N, Stecher M, Pilgram L, Vehreschild JJ; LEOSS Study Group; Hanses F, Luedde T, Jensen B. Freise NF, et al. Sci Rep. 2022 Nov 9;12(1):19035. doi: 10.1038/s41598-022-23200-1. Sci Rep. 2022. PMID: 36351986 Free PMC article.
Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry.
Schmidt-Hellerau K, Raichle C, Ruethrich MM, Vehreschild JJ, Lanznaster J, Nunes de Miranda SM, Bausewein C, Vehreschild MJGT, Koll CEM, Simon ST, Hellwig K, Jensen BO, Jung N; LEOSS Study Group. Schmidt-Hellerau K, et al. Infection. 2023 Aug;51(4):1119-1126. doi: 10.1007/s15010-023-02020-z. Epub 2023 Mar 23. Infection. 2023. PMID: 36952127 Free PMC article.
Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Schons MJ, Caliebe A, Spinner CD, Classen AY, Pilgram L, Ruethrich MM, Rupp J, Nunes de Miranda SM, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degenhardt C, Borgmann S, Hower M, Hanses F, Haselberger M, Friedrichs AK; LEOSS-study group. Schons MJ, et al. Infection. 2022 Apr;50(2):437-438. doi: 10.1007/s15010-021-01727-1. Infection. 2022. PMID: 34913136 Free PMC article. No abstract available.
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients.
Eliadou E, Moleiro J, Ribaldone DG, Astegiano M, Rothfuss K, Taxonera C, Ghalim F, Carbonnel F, Verstockt B, Festa S, Maia L, Berrozpe A, Zagorowicz E, Savarino E, Ellul P, Vavricka SR, Calvo M, Koutroubakis I, Hoentjen F, Salazar LF, Callela F, Cañete Pizarro F, Soufleris K, Sonnenberg E, Cavicchi M, Wypych J, Hommel C, Ghiani A, Fiorino G; ECCO CONFER COMMITTEE. Eliadou E, et al. Among authors: rothfuss k. J Crohns Colitis. 2020 May 21;14(4):480-489. doi: 10.1093/ecco-jcc/jjz165. J Crohns Colitis. 2020. PMID: 31602473 Free article.
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Schons MJ, Caliebe A, Spinner CD, Classen AY, Pilgram L, Ruethrich MM, Rupp J, Nunes de Miranda SM, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degenhardt C, Borgmann S, Hower M, Hanses F, Haselberger M, Friedrichs AK; LEOSS-study group. Schons MJ, et al. Infection. 2022 Apr;50(2):423-436. doi: 10.1007/s15010-021-01699-2. Epub 2021 Oct 8. Infection. 2022. PMID: 34625912 Free PMC article.
24 results